Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,780Revenue (TTM) $M2,415Net Margin (%)-2.8Altman Z-Score0.9
Enterprise Value $M6,860EPS (TTM) $-1.0Operating Margin %2.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-6.1Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yN
Price/Free Cash Flow19.5y-y EBITDA Growth Rate %-26.1ROA % (ttm)-1.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-4.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.7ROIC % (ttm)1.0Gross Margin Increase y-yN

Gurus Latest Trades with ALR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALRPrivate Capital 2016-06-30 Reduce-0.53%$39 - $50.62
($43.5)
$ 43.580%Reduce -8.97%849,998
ALRLeucadia National 2016-06-30 Buy 0.38%$39 - $50.62
($43.5)
$ 43.580%New holding79,457
ALRKeeley Asset Management Corp 2016-06-30 Reduce-0.37%$39 - $50.62
($43.5)
$ 43.580%Reduce -27.09%520,100
ALRFirst Eagle Investment 2016-06-30 Buy 0.08%$39 - $50.62
($43.5)
$ 43.580%New holding766,566
ALRGeorge Soros 2016-06-30 Sold Out -0.06%$39 - $50.62
($43.5)
$ 43.580%Sold Out0
ALRMario Gabelli 2016-06-30 Add0.01%$39 - $50.62
($43.5)
$ 43.580%Add 6.91%528,225
ALRKeeley Asset Management Corp 2016-03-31 Reduce-0.31%$35.47 - $54.11
($47.67)
$ 43.58-9%Reduce -26.02%713,314
ALRMario Gabelli 2016-03-31 Add0.08%$35.47 - $54.11
($47.67)
$ 43.58-9%Add 109.87%494,105
ALRGeorge Soros 2016-03-31 Buy 0.06%$35.47 - $54.11
($47.67)
$ 43.58-9%New holding42,800
ALRPrivate Capital 2016-03-31 Add0.02%$35.47 - $54.11
($47.67)
$ 43.58-9%Add 0.34%933,725
ALRPrivate Capital 2015-12-31 Reduce-0.06%$38.21 - $50.57
($42.74)
$ 43.582%Reduce -1.20%930,548
ALRKeeley Asset Management Corp 2015-12-31 Reduce-0.01%$38.21 - $50.57
($42.74)
$ 43.582%Reduce -1.01%964,189
ALRMario Gabelli 2015-12-31 Add$38.21 - $50.57
($42.74)
$ 43.582%Add 0.86%235,430
ALRKeeley Asset Management Corp 2015-09-30 Reduce-0.09%$45.76 - $55.39
($51.83)
$ 43.58-16%Reduce -6.81%974,047
ALRPrivate Capital 2015-09-30 Add0.08%$45.76 - $55.39
($51.83)
$ 43.58-16%Add 1.59%941,823
ALRMario Gabelli 2015-09-30 Add$45.76 - $55.39
($51.83)
$ 43.58-16%Add 6.88%233,430
ALRKeeley Asset Management Corp 2015-06-30 Reduce-0.2%$47.48 - $52.75
($50.3)
$ 43.58-13%Reduce -15.76%1,045,227
ALRPrivate Capital 2015-06-30 Add0.09%$47.48 - $52.75
($50.3)
$ 43.58-13%Add 1.74%927,113
ALRMario Gabelli 2015-06-30 Add$47.48 - $52.75
($50.3)
$ 43.58-13%Add 4.92%218,400
ALRJoel Greenblatt 2015-03-31 Sold Out -0.12%$36.72 - $49.06
($43.88)
$ 43.58-1%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Guerdan MelissaSVP, Global Quality & Reg. 2016-02-01Sell2,500$54-19.3view
Hargadon Robert BernardSVP, Global Human Resources 2015-11-13Buy1,000$38.9911.77view
Hinrichs James F.Executive VP, CFO 2015-11-12Buy10,000$39.979.03view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-03Sell5,135$52-16.19view
Gladwell MarkSenior VP, Global Operations 2015-09-03Sell2,651$52.27-16.63view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-01Sell5,000$50.48-13.67view
Gladwell MarkSenior VP, Global Operations 2015-08-31Sell27,513$52.23-16.56view
Malkani SanjayGlobal Pres., Toxicology 2015-08-14Sell31,460$54.6-20.18view
Hinrichs James F.Executive VP, CFO 2015-08-07Buy20,000$49.33-11.66view
Malkani SanjayGlobal Pres., Toxicology 2015-06-08Sell24,331$50.87-14.33view

Press Releases about ALR :

Quarterly/Annual Reports about ALR:

News about ALR:

Articles On GuruFocus.com
Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Jun 18 2016 
Keeley Small Cap Value Fund 1st Quarter Commentary Apr 26 2016 
The Transformation in Alere May 22 2015 
Diamond Hill Capital Comments on Alere Inc Mar 17 2015 
Corsair Capital's Analysis of Alere Mar 06 2015 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
Mario Gabelli Comments on Alere Inc Nov 21 2014 
Mario Gabelli’s Asset Fund Q3 2014 Commentary Nov 21 2014 
Cohen Has Busy Third Quarter Nov 19 2014 

More From Other Websites
Screening company, 235 jobs jump state line to south KC Sep 22 2016
Abbott Laboratories -- Moody's expectations for Abbott's ratings unchanged following news of medical... Sep 19 2016
Abbott's Eye Deal Isn't About Alere Sep 19 2016
J&J (JNJ) to Buy Abbott's Vision Care Unit for $4.3 Billion Sep 19 2016
Pharos Capital Acquires TechLab, Leading Developer of Gastrointestinal Disease Diagnostics Sep 19 2016
Alro to start a Project co-funded by the Regional Development European Fund Sep 19 2016
[$$] J&J to Buy Abbott’s Eye-Surgery Equipment Unit for $4.325 billion Sep 16 2016
[$$] J&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion Sep 16 2016
Abbott to sell its eye care business to J&J for about $4.33 bln Sep 16 2016
Johnson & Johnson Sees Growth in Ophthalmology, Acquires Abbott Medical Optics Sep 16 2016
Expiry of the validity of the basic Alior Bank SA bonds issuance prospectus Sep 16 2016
Current report in compliance with Regulation no. 1/2006 of NSC and with the stipulations of article... Sep 15 2016
Current report as per art.113 item A letter j) of the National Securities Commission’s Regulation... Sep 15 2016
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock Sep 14 2016
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock Sep 14 2016
Can Abbott Labs Find a Cure for Its Ailing Shares? Sep 12 2016
ALERE INC. Financials Sep 09 2016
Abbott, Alere agree to mediate merger dispute Sep 08 2016
Abbott, Alere agree to mediate merger dispute Sep 08 2016
Alere, Inc. – Value Analysis (NYSE:ALR) : September 8, 2016 Sep 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)